Literature DB >> 15507294

The appearance and disappearance of antiphospholipid autoantibodies subsequent to oxidation--reduction reactions.

John A McIntyre1.   

Abstract

The mechanisms that cause the appearance of autoantibodies are not understood. Compared to normal antibody production, factors responsible for autoantibody synthesis are more complex; they are thought to disrupt the normal mechanisms proposed to eliminate or down-regulate self-antibodies or to interfere with anti-self-receptor editing. Data presented show that autoantibodies exist in the blood of all normal individuals. The autoantibodies appear after simple oxidation-reduction (redox) reactions and react by ELISA, immunofluorescence, flow cytometry, Western blots, and in lupus anticoagulant (LA) assays. Antiphospholipid antibody (aPL) specificities detected after redox are cardiolipin (aCL), antiphosphatidylserine (aPS), antiphosphatidylethanolamine (aPE), antiphosphatidylcholine (aPC), and LA. These antibody activities were confirmed in several outside laboratories. The aPL isotypes detected in ELISA are plasma protein-dependent and include IgG, IgA, and IgM. Oxidizing agents tested to date include hemin, KMnO4, and NaIO4. Furthermore, aPL appear after exposure to direct current (DC)-mediated electromotive force. Alternating current (AC) is ineffective. Commercial IvIg preparations, also a source of IgG autoantibodies, provide a less complex milieu than plasma or serum for studying the biology of aPL redox-mediated mechanisms. Inhibition of hemin-mediated IvIg aPL conversion can be achieved by the addition of antioxidants, e.g., ascorbic acid, hemopexin, apotransferrin, and by addition of normal plasma or serum. Remarkably, the aPL specificities in the blood of autoimmunity patients disappear subsequent to application of redox reactions. These data document the hitherto unknown existence of redox-reactive autoantibodies in all normal individuals. The evolutionary persistence of these redox-sensitive antibodies raises interesting possibilities about their potentially beneficial role in immunological homeostasis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15507294     DOI: 10.1016/j.thromres.2004.08.008

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  9 in total

Review 1.  Do antiphospholipid antibodies develop for a purpose?

Authors:  Joan T Merrill
Journal:  Curr Rheumatol Rep       Date:  2006-04       Impact factor: 4.592

2.  The acquisition of narrow binding specificity by polyspecific natural IgM antibodies in a semi-physiological environment.

Authors:  Qili Chu; James J Ludtke; Vladimir M Subbotin; Andrey Blockhin; Alex V Sokoloff
Journal:  Mol Immunol       Date:  2007-11-05       Impact factor: 4.407

Review 3.  Redox-reactive autoantibodies: biochemistry, characterization, and specificities.

Authors:  John A McIntyre; W Page Faulk
Journal:  Clin Rev Allergy Immunol       Date:  2009-08       Impact factor: 8.667

4.  Prevalence and gene characteristics of antibodies with cofactor-induced HIV-1 specificity.

Authors:  Maxime Lecerf; Tobias Scheel; Anastas D Pashov; Annaelle Jarossay; Delphine Ohayon; Cyril Planchais; Stephane Mesnage; Claudia Berek; Srinivas V Kaveri; Sébastien Lacroix-Desmazes; Jordan D Dimitrov
Journal:  J Biol Chem       Date:  2015-01-06       Impact factor: 5.157

5.  Autoimmune reactivity of IgM acquired after oxidation.

Authors:  Jasna Omersel; Ivica Avberšek-Lužnik; Pegi Ahlin Grabnar; Tanja Kveder; Blaž Rozman; Borut Božič
Journal:  Redox Rep       Date:  2011       Impact factor: 4.412

6.  A cryptic polyreactive antibody recognizes distinct clades of HIV-1 glycoprotein 120 by an identical binding mechanism.

Authors:  Jordan D Dimitrov; Cyril Planchais; Tobias Scheel; Delphine Ohayon; Stephane Mesnage; Claudia Berek; Srinivas V Kaveri; Sébastien Lacroix-Desmazes
Journal:  J Biol Chem       Date:  2014-05-06       Impact factor: 5.157

Review 7.  Breaking the law: unconventional strategies for antibody diversification.

Authors:  Alexia Kanyavuz; Annaelle Marey-Jarossay; Sébastien Lacroix-Desmazes; Jordan D Dimitrov
Journal:  Nat Rev Immunol       Date:  2019-06       Impact factor: 53.106

8.  Aromatic Guanylhydrazones for the Control of Heme-Induced Antibody Polyreactivity.

Authors:  Nina Božinović; Vladimir Ajdačić; Jelena Lazic; Maxime Lecerf; Victoria Daventure; Jasmina Nikodinovic-Runic; Igor M Opsenica; Jordan D Dimitrov
Journal:  ACS Omega       Date:  2019-11-22

9.  Functional Changes of Therapeutic Antibodies upon Exposure to Pro-Oxidative Agents.

Authors:  Maxime Lecerf; Robin Lacombe; Alexia Kanyavuz; Jordan D Dimitrov
Journal:  Antibodies (Basel)       Date:  2022-02-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.